AMA Ed Hub Logo

Get fast-track DEA training from AMA Ed Hub™
Red JAMA Logo

Learn more on substance use disorders from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on substance use disorders from PolicyFinder
Mature patient talking with psychotherapist in an office

Care for substance use disorder guide

Updated
| 3 Min Read
Clear Search
·
4 Min Read

AMA adopts new policies on substance use during second day of Annual Meeting

Policies address opioid crisis and medicinal use of psychedelics.

Press Releases
AMA in Action: Ending the overdose epidemic
UPDATED
·
4 Min Read

Advocacy in action: Ending the overdose epidemic

Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.

Behavioral Health
Narcan nasal spray
·
4 Min Read

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Behavioral Health
Katherine Pannel, DO
·
6 Min Read

How this DO’s advocacy will help prevent drug-overdose deaths

AMA member Katherine Pannel, DO, helped persuade lawmakers to decriminalize fentanyl test strips in Mississippi. Learn more.

Behavioral Health
·
3 Min Read

AMA launches resource to help physicians meet DEA training requirement

The AMA Ed Hub™ has a new educational webpage for physicians to complete required training on treating patients with opioid or other substance use disorders.

Press Releases
Rahul Gupta, MD, speaking at the 2023 National Advocacy Conference
·
5 Min Read

Every 5 minutes a person dies of drug overdose. This must end.

Rahul Gupta, MD, MPH, is the first physician to direct the White House’s drug-control policy. Learn why he says treatment is key to the strategy.

Behavioral Health
·
2 Min Read

AMA statement on making naloxone available over the counter

The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.

Press Releases
Pregnant patient and physician
·
4 Min Read

Stepping up to help pregnant patients with substance-use disorders

AMA member Ruchi Fitzgerald, MD, helps run an innovative effort to help pregnant patients and others with substance-use disorder get lifesaving care.

Behavioral Health
·
2 Min Read

AMA: FDA panels’ naloxone recommendation will save lives

Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.

Press Releases